CRL
Income statement / Annual
Last year (2023), Charles River Laboratories International, Inc.'s total revenue was $4.13 B,
an increase of 3.86% from the previous year.
In 2023, Charles River Laboratories International, Inc.'s net income was $474.62 M.
See Charles River Laboratories International, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/30/2023 |
12/31/2022 |
12/25/2021 |
12/26/2020 |
12/28/2019 |
12/29/2018 |
12/30/2017 |
12/31/2016 |
12/26/2015 |
12/27/2014 |
| Operating Revenue |
$4.13 B
|
$3.98 B
|
$3.54 B
|
$2.92 B
|
$2.62 B
|
$2.27 B
|
$1.86 B
|
$1.68 B
|
$1.36 B
|
$1.30 B
|
| Cost of Revenue |
$2.63 B |
$2.51 B |
$2.21 B |
$1.85 B |
$1.66 B |
$1.43 B |
$1.16 B |
$1.03 B |
$832.21 M |
$825.00 M |
| Gross Profit |
$1.50 B |
$1.46 B |
$1.33 B |
$1.07 B |
$958.31 M |
$840.07 M |
$702.31 M |
$646.67 M |
$531.09 M |
$472.66 M |
| Gross Profit Ratio |
0.36 |
0.37 |
0.38 |
0.37 |
0.37 |
0.37 |
0.38 |
0.38 |
0.39 |
0.36 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$747.86 M
|
$665.10 M
|
$619.92 M
|
$528.94 M
|
$517.62 M
|
$443.85 M
|
$373.45 M
|
$367.55 M
|
$300.41 M
|
$269.03 M
|
| Other Expenses |
$0.00 |
$146.58 M |
$124.86 M |
$111.88 M |
$89.54 M |
$13.26 M |
$38.54 M |
$11.90 M |
$3.01 M |
$10.72 M |
| Operating Expenses |
$885.30 M |
$811.68 M |
$744.78 M |
$640.81 M |
$607.16 M |
$508.68 M |
$414.82 M |
$409.25 M |
$324.64 M |
$294.99 M |
| Cost And Expenses |
$3.51 B |
$3.33 B |
$2.95 B |
$2.49 B |
$2.27 B |
$1.93 B |
$1.57 B |
$1.44 B |
$1.16 B |
$1.12 B |
| Interest Income |
$5.20 M |
$780,000.00 |
$652,000.00 |
$834,000.00 |
$1.52 M |
$812,000.00 |
$690,000.00 |
$1.31 M |
$1.04 M |
$1.15 M |
| Interest Expense |
$136.71 M |
$59.29 M |
$73.91 M |
$86.43 M |
$60.88 M |
$63.77 M |
$29.78 M |
$27.71 M |
$15.07 M |
$11.95 M |
| Depreciation &
Amortization |
$314.12 M
|
$303.87 M
|
$265.54 M
|
$234.92 M
|
$198.10 M
|
$161.78 M
|
$131.16 M
|
$126.66 M
|
$24.23 M
|
$25.96 M
|
| EBITDA |
$1.03 B
|
$1.04 B
|
$854.29 M
|
$759.15 M
|
$581.73 M
|
$507.23 M
|
$457.89 M
|
$377.29 M
|
$305.38 M
|
$285.99 M
|
| EBITDA Ratio |
0.25 |
0.25 |
0.23 |
0.26 |
0.21 |
0.18 |
0.2 |
0.17 |
0.17 |
0.16 |
| Operating Income Ratio
|
0.15
|
0.16
|
0.17
|
0.15
|
0.13
|
0.15
|
0.15
|
0.14
|
0.15
|
0.14
|
| Total Other
Income/Expenses Net |
-$35.98 M
|
-$27.99 M
|
-$109.15 M
|
$14.39 M
|
-$47.07 M
|
-$49.70 M
|
$8.67 M
|
-$14.50 M
|
-$11.02 M
|
-$75,000.00
|
| Income Before Tax |
$581.28 M |
$622.99 M |
$480.71 M |
$447.11 M |
$304.08 M |
$281.68 M |
$296.96 M |
$222.92 M |
$195.43 M |
$177.60 M |
| Income Before Tax Ratio
|
0.14
|
0.16
|
0.14
|
0.15
|
0.12
|
0.12
|
0.16
|
0.13
|
0.14
|
0.14
|
| Income Tax Expense |
$100.91 M |
$130.38 M |
$81.87 M |
$81.81 M |
$50.02 M |
$54.46 M |
$171.37 M |
$66.84 M |
$43.39 M |
$47.67 M |
| Net Income |
$474.62 M |
$486.23 M |
$390.98 M |
$364.30 M |
$252.02 M |
$226.37 M |
$123.36 M |
$154.77 M |
$149.31 M |
$126.70 M |
| Net Income Ratio |
0.11 |
0.12 |
0.11 |
0.12 |
0.1 |
0.1 |
0.07 |
0.09 |
0.11 |
0.1 |
| EPS |
9.27 |
9.57 |
7.77 |
7.35 |
5.17 |
4.72 |
2.6 |
3.29 |
3.21 |
2.72 |
| EPS Diluted |
9.22 |
9.48 |
7.6 |
7.2 |
5.07 |
4.62 |
2.54 |
3.23 |
3.13 |
2.66 |
| Weighted Average Shares
Out |
$51.23 M
|
$50.81 M
|
$50.29 M
|
$49.55 M
|
$48.73 M
|
$47.95 M
|
$47.48 M
|
$47.01 M
|
$46.50 M
|
$46.63 M
|
| Weighted Average Shares
Out Diluted |
$51.45 M
|
$51.30 M
|
$51.43 M
|
$50.61 M
|
$49.69 M
|
$49.02 M
|
$48.56 M
|
$47.96 M
|
$47.63 M
|
$47.56 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
